These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10868304)

  • 1. Bioavailability and bioequivalence: average, population and/or individual.
    Colburn WA; Keefe DL
    J Clin Pharmacol; 2000 Jun; 40(6):559-60. PubMed ID: 10868304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence].
    Blume H
    Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies.
    Hellriegel ET; Bjornsson TD; Hauck WW
    Clin Pharmacol Ther; 1996 Dec; 60(6):601-7. PubMed ID: 8988062
    [No Abstract]   [Full Text] [Related]  

  • 4. Society testifies on bioavailability, bioequivalence.
    Hayes AH
    Pa Med; 1975 Sep; 78(9):59-60. PubMed ID: 1178207
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview on bioavailability and bioequivalence.
    Kaplan SA
    Psychopharmacol Bull; 1976 Oct; 12(4):50-1. PubMed ID: 972989
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmonization of bioavailability and bioequivalence requirements.
    McGilveray IJ; Ormsby E
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():533-40. PubMed ID: 1820935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bioavailability and bioequivalence of dignoxin and digitoxin preparations].
    Weyers W; Meinecke M; Brodbeck R
    Pharm Acta Helv; 1979; 54(6):173-9. PubMed ID: 515104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bioavailability and the assessment of bioequivalence in the control of pharmaceutical preparations].
    Ciranni Signoretti E
    Ann Ist Super Sanita; 1982; 18(3):547-50. PubMed ID: 7187843
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing individual bioequivalence using the structural equation model.
    Carrasco JL; Jover L
    Stat Med; 2003 Mar; 22(6):901-12. PubMed ID: 12627408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian modeling of multivariate average bioequivalence.
    Ghosh P; Gönen M
    Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and bioequivalence of topical glucocorticoids.
    Wiedersberg S; Leopold CS; Guy RH
    Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioequivalence of generic drugs: sense and nonsense].
    Brune K; Dietzel K
    Fortschr Med; 1988 Nov; 106(33):16-7. PubMed ID: 3209169
    [No Abstract]   [Full Text] [Related]  

  • 14. Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals.
    Esinhart JD; Chinchilli VM
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):26-32. PubMed ID: 8199749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioequivalence of generic drugs].
    Schwabe U
    Internist (Berl); 1988 Mar; 29(3):147-59. PubMed ID: 3288573
    [No Abstract]   [Full Text] [Related]  

  • 16. Branded versus generic clozapine: bioavailability comparison and interchangeability issues.
    Lam YW; Ereshefsky L; Toney GB; Gonzales C
    J Clin Psychiatry; 2001; 62 Suppl 5():18-22; discussion 23-4. PubMed ID: 11305844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of bioequivalence trials. From analysis to statistic trials].
    Houin G
    Therapie; 1993; 48(4):289-95. PubMed ID: 8128417
    [No Abstract]   [Full Text] [Related]  

  • 18. Dilemma with matrix effect in bioanalysis--perspectives from bioavailability/bioequivalence studies for product registration?
    Srinivas NR
    Drug Res (Stuttg); 2014 Jun; 64(6):335-6. PubMed ID: 24258702
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic drugs: bioequivalence and bioavailability.
    Ansbacher R
    JAMA; 1988 Jan; 259(2):220. PubMed ID: 2826829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.